GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuhan Corp (XKRX:000100) » Definitions » Accounts Payable & Accrued Expense

Yuhan (XKRX:000100) Accounts Payable & Accrued Expense : ₩252,717 Mil (As of Mar. 2024)


View and export this data going back to 1962. Start your Free Trial

What is Yuhan Accounts Payable & Accrued Expense?

Yuhan's quarterly accounts payable & accrued expense declined from Sep. 2023 (₩275,239 Mil) to Dec. 2023 (₩258,975 Mil) and declined from Dec. 2023 (₩258,975 Mil) to Mar. 2024 (₩252,717 Mil).

Yuhan's annual accounts payable & accrued expense declined from Dec. 2021 (₩222,522 Mil) to Dec. 2022 (₩201,920 Mil) but then increased from Dec. 2022 (₩201,920 Mil) to Dec. 2023 (₩258,975 Mil).

Yuhan Accounts Payable & Accrued Expense Historical Data

The historical data trend for Yuhan's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yuhan Accounts Payable & Accrued Expense Chart

Yuhan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 145,334.51 207,069.72 222,522.27 201,919.61 258,974.72

Yuhan Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 256,882.69 232,389.84 275,238.68 258,974.72 252,716.61

Yuhan Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Yuhan (XKRX:000100) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuhan Corp (XKRX:000100) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
XKRX:128940 XKRX:068760 XKRX:009420 XKRX:000250 XKRX:237690 XKRX:195940 XKRX:069620 XKRX:185750 XKRX:006280 XKRX:086450 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
000105:Korea
Address
74, Noryangjin-ro, Dongjak-gu, Seoul, KOR
Website
http://www.yuhan.co.kr
Yuhan Corp is a pharmaceutical company. The core business of the company is classified as primary and specialty care, dietary supplement, household and animal care, and contract manufacturing of active pharmaceutical ingredients. Yuhan offers one-stop custom synthesis services from research and development to commercial production of active pharmaceutical products (APIs) and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.

Yuhan (XKRX:000100) Headlines

No Headlines